The endocannabinoid 2-arachidonoylglycerol (2-AG) is predominantly biosynthesized by sn-1-diacylglycerol lipase α (DAGL-α) in the central nervous system. Selective inhibitors of DAGL-α will provide valuable insights in the role of 2-AG in endocannabinoid signaling processes and are potential therapeutics for the treatment of obesity and neurodegenerative diseases. Here, we describe the development of a natural substrate-based fluorescence assay for DAGL-α, using a coupled enzyme approach. The continuous setup of our assay allows monitoring of DAGL-α activity in real-time and in a 96-well plate format. This constitutes a major improvement to the currently available radiometric and LC/MS-based methods, which can be executed only in low-throughput formats. In addition, our assay circumvents the use of radioactive material. We demonstrate that our assay can be used to screen inhibitors of DAGL-α activity, using 1-stearoyl-2-arachidonoyl-sn-glycerol as the physiologically relevant, natural substrate of DAGL-α. Furthermore, our method can be employed to measure DAGL activity and inhibition in the mouse brain membrane proteome. Consequently, our assay should serve as a valuable tool for rapid hit validation and lead optimization of DAGL-α inhibitors.
Introduction
2-Arachidonoylglycerol (2-AG) is the most abundant endocannabinoid in the central nervous system (CNS) and activates the endocannabinoid system by binding to the cannabinoid 1 (CB1) receptor (1) . Its local action is highly dependent on site-specific production by sn-1-diacylglycerol lipase α (DAGL-α), the major enzyme responsible for 2-AG biosynthesis in the CNS (2, 3) . DAGL-α is an intracellular, integral, multi-domain membrane protein and employs a typical Ser-His-Asp catalytic triad to selectively hydrolyze the sn-1 acyl group of diacylglycerol (4) . Selective inhibitors of DAGL-α will provide valuable insights in the role of 2-AG in endocannabinoid signaling processes and have therapeutic potential for the treatment of obesity and neurodegenerative diseases (5) (6) (7) .
A limited number of DAGL-α activity assays is currently available. The first group of assays employs surrogate substrates, such as para-nitrophenol butyrate, and is generally used for the initial process of inhibitor identification. The main advantage of these assays is that product formation can be monitored in real-time, generally by absorption or fluorescence measurement. The cost-effectiveness and easy detection of surrogate substrates make these assays valuable tools for high-throughput screening applications (8, 9) . However, surrogate substrates generally have an attenuated binding affinity for the enzyme active site compared to physiologically relevant, natural substrates, which may lead to distorted results when determining inhibitory potency. Consequently, the use of the natural substrate of DAGL-α is preferred in the process of hit validation and lead optimization.
At present, two assay methods have been reported that utilize diacylglycerol, the natural substrate of DAGL-α. A radiometric assay has been extensively used to measure DAGL-α activity in vitro, using 1-stearoyl-2-[ 14 C]arachidonoyl-sn-glycerol as the substrate (4) . This method is highly sensitive, but requires lipid extraction, fractionation by thin layer chromatography (TLC) and quantification of radiolabeled 2- DMEM without serum. The empty pcDNA3.1 vector served as a mock-control. After 24 hours, the medium was refreshed. Cells were harvested 72 hours after transfection by resuspension and centrifuged for 10 min at 200 g. Supernatant was discarded, cell pellets were frozen in liquid nitrogen and stored at -80°C for at least 24 hours.
Cell pellets were thawed on ice and resuspended in lysis buffer A (20 mM HEPES pH 7.2, 2 mM DTT, 250 mM sucrose, 1 mM MgCl2 and 25 U/mL benzonase). Suspensions were homogenized by polytrone (3 x 7 seconds, 20,000 rpm, SilentCrusher S, Heidolph, Schwabach, Germany), incubated on ice for 30 min and subsequently centrifuged at 93,000 g for 30 min at 4°C (Ti70 or Ti70.1 rotor, Beckman Coulter, Woerden, The Netherlands). Pellet was resuspended in storage buffer B (20 mM HEPES pH 7.2, 2 mM DTT). Suspension was homogenized by polytrone (1 x 10 seconds, 20,000 rpm). Protein concentrations were determined with Quick Start Bradford Reagent (BioRad, Hilversum, The Netherlands) or Qubit fluorometric quantitation (Life Technologies, Breda, The Netherlands). Membranes were diluted with storage buffer B to the desired concentration, aliquoted, frozen in liquid nitrogen and stored at -80°C.
Preparation of mouse brain membrane proteome
Mouse brains were isolated according to guidelines approved by the ethical committee of Leiden University (DEC#13191), frozen in liquid nitrogen and stored at -80°C until use. Mouse brains were thawed on ice and homogenized by polytrone (3 x 5 seconds, 20,000 rpm) in lysis buffer A (20 mM HEPES pH 7.2, 2 mM DTT, 250 mM sucrose, 1 mM MgCl2 and 25 U/mL benzonase). The suspension was incubated on ice for 15 min, followed by low speed centrifugation (2500 g, 3 min. at 4°C) to remove debris. The supernatant was subjected to ultracentrifugation (93,000 g, 45 min at 4°C) to yield the mouse brain membrane proteome as a pellet. The pellet was resuspended in storage buffer B (20 mM HEPES pH 7.2, 2 mM DTT) and homogenized by polytrone (1 x 7 seconds, 20,000 rpm). Protein concentrations were determined and membranes preparations were stored as described above.
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Activity-based protein profiling
Gels and blots were scanned with a ChemiDoc XRS system (BioRad) and images were analyzed with Image Lab software (BioRad). For ABPP experiments, 20 µL of protein sample (2 mg/mL) was preincubated with 0.5 µL inhibitor (10 µM final concentration) for 20 min at RT. Subsequently, 0.5 µL TAMRA-FP or MB064 (500 nM final concentration, in DMSO) was added and the samples were incubated for 15 min at RT. The reaction was quenched by addition of 10 µL 3x Laemmli sample buffer (final concentrations: 60 mM Tris-Cl pH 6.8, 2% (w/v) SDS, 10% (v/v) glycerol, 5% (v/v) β-mercaptoethanol, 0.01% (v/v) bromophenol blue). Samples were centrifuged for 2 min at 9,300 g and were then loaded on a 10% acrylamide SDS-PAGE gel. Gels were run at 180 V for 60-90 min and scanned for fluorescence using Cy3 and Cy5 multichannel settings (605/50 and 695/55 filters, respectively).
Proteins on SDS-PAGE gels were transferred to 0.2 µm PVDF membranes (Trans-Blot Turbo™ Transfer system, BioRad). The membrane was blocked with blocking buffer (5% (w/v) milk in 10 mL TBSTween) and then stained with primary mouse-anti-FLAG antibody (0.1% (v/v), Sigma) and goat-antimouse-HRP (0.02% (v/v), Santa Cruz Biotechnology, Heidelberg, Germany), each for 1 hour. Imaging solution (10 mL luminal, 100 µL ECL enhancer, 3 µL H2O2) was added and the blot was scanned using chemiluminescence settings.
DAGL-α activity assay
The DAGL-α natural substrate assay is based on the production of 2-AG from 1-stearoyl-2-arachidonoylsn-glycerol (SAG) hydrolysis by DAGL-α-overexpressing membrane preparations from transiently transfected HEK293T cells. The 2-AG production is coupled to the oxidation of commercially available Amplifu™Red via a multi-enzyme cascade, resulting in a fluorescent signal from the dye resorufin (13) . 
MAGL activity assay
The MAGL activity assay is based on the production of glycerol from 2-AG hydrolysis by MAGLoverexpressing membrane preparations from transiently transfected HEK293T cells, as previously reported (13) . Standard assays were performed under similar conditions as for the DAGL-α activity assay, but at a final protein concentration of 1.5 μg/mL (0.3 μg MAGL-overexpressing membranes per well) and with 2-arachidonoylglycerol (2-AG) as the substrate. 2-AG was directly added from a stock solution in acetonitrile and no Triton X-100 was added. Fluorescence was measured in 5 min intervals for 60 min. 
Data analysis and statistics
For the DAGL-α and MAGL activity assay, data were corrected for the average fluorescence of the negative control (mock-membranes + DMSO), unless mentioned otherwise. For the mouse brain membrane proteome assay, membranes with no added substrate served as a negative control. DAGL-α-overexpressing, MAGL-overexpressing, or mouse brain membranes + DMSO served as a positive control, respectively. Slopes of fluorescence in time were determined in the linear interval of t = 10 to t = 25 min (Michaelis-Menten experiment), t = 0 to t = 15 min (mouse brain membrane proteome assay with 2-AG) or t = 10 to t = 35 min (all other assays). If relevant, experimental data were converted into 2-AG or glycerol production rates in pmol/min or nmol/mg protein/min according to a glycerol standard curve.
For each data set, mean, standard deviation and standard error of mean were calculated. For Km and Vmax determination, the data was exported to GraphPad Prism 5.0 and subjected to Michaelis-Menten analysis. 
Results and discussion
The DAGL-α natural substrate assay is based on the production of 2-AG from 1-stearoyl-2-arachidonoyl-sn-glycerol (SAG) hydrolysis by DAGL-α-overexpressing membrane preparations from transiently transfected HEK293T cells. The produced glycerol is coupled to the oxidation of commercially available Amplifu™Red via a coupled enzyme reaction, resulting in a fluorescent signal from the dye resorufin (Fig. 1A) . The assay setup is derived from a previously reported monoacylglycerol lipase assay (13) . We reasoned that MAGL was the best candidate to participate in the enzymatic cascade, since previous studies indicated that this enzyme was more efficient at 2-AG hydrolysis than the other two endocannabinoid hydrolases, ABHD6 and ABHD12 (13) . Fig. 1B shows an overview of the inhibitors and probes that were used in our experiments.
Activity and expression of full-length human DAGL-α and MAGL was verified by activity-based protein profiling and Western blotting, respectively (Fig. 2) . Broad-range serine hydrolase probe TAMRA-FP labeled MAGL as a doublet (~33 and ~35 kDa), likely due to alternative splicing (16) . Our previously reported activity-based probe MB064 was used to verify catalytic activity of DAGL-α (~120 kDa). The marked band at ~70 kDa likely corresponds to a degradation product of DAGL-α, whose catalytic activity is maintained. In contrast, no band is observed on Western blot, suggesting that the enzyme's C-terminal domain containing the FLAG-tag is no longer present. These observations are in line with prior experiments using a C-terminal deletion construct of DAGL-α (14) . No labeling was observed in case MAGL was preincubated with the selective irreversible MAGL inhibitor JZL184 (17), nor upon preincubation of DAGL-α with potent irreversible DAGL inhibitor KT109 (10). Mutating DAGL-α's catalytic Ser472 residue into an alanine abolished labeling by MB064, whereas protein expression was unaltered.
1-stearoyl-2-arachidonoyl-sn-glycerol hydrolysis by the isolated DAGL-α-overexpressing membrane preparations could be monitored by detection of fluorescent resorufin (Fig. 3A,B) . Incubation of the DAGL-α-membranes with KT109 reduced the signal to mock-levels, indicating that the signal was truly activity-based. To verify that KT109 inhibited DAGL-α activity, rather than the activity of any 12 downstream coupling enzymes, a MAGL validation assay was performed (Fig. 4B) . Indeed, 2-AG hydrolysis by MAGL-overexpressing membrane preparations was unaffected upon treatment with KT109, which is in line with the selectivity profile of KT109 based on ABPP experiments in a previous report (10) .
Under the employed assay conditions, the progression curve displayed steady state kinetics from 2 to 40 min. After 40-45 min the fluorescence signal reached a plateau, whereas the background signal continued to increase. We used the linear interval of t = 10 to t = 35 min to determine the reaction rate of the enzyme. Interestingly, and in contrast to previous reports (4, 8) , the addition of calcium in the assay buffer did not result in increase of the DAGL-α-specific signal, possibly because this affected the downstream enzymatic cascade.
Limited substrate solubility and availability is a common issue encountered in lipase assay development and also proved to be a challenge in the optimization of this assay. Sonication of SAG in buffer and the use of organic solvents, such as dimethyl sulfoxide, ethanol or ethyl acetate, resulted in a lack of DAGL-α specific signal or an increase in background fluorescence. Stepwise dissolution of SAG, first in buffer with high Triton X-100 concentration, followed by dilution in the assay buffer, turned out to be crucial to establish substrate availability. DAGL-α appears to be highly susceptible to addition of detergents in the assay buffer, possibly because it is an integral membrane protein that needs an intact membrane environment to maintain its structure and catalytic activity (3) . Under the employed assay conditions, we observed a DAGL-α specific signal only in a narrow range of Triton X-100 concentrations, typically between 0.0075% and 0.075% (w/v).
To quantify the observed DAGL-α activity in the assay, we generated a glycerol standard curve with fluorescence intensity as a function of converted glycerol (Fig. 3C ). This curve allowed us to convert experimentally measured slopes in RFU/min into 2-AG production rates in nmol/mg/min, assuming 1-to-equal increase of background fluorescence by mock-membrane controls. For this reason, 50 μg/mL DAGL-α-overexpressing membranes (10 μg/well) was chosen as the optimal protein concentration.
In a similar way, DAGL-α activity was measured at various SAG concentrations (Fig. 3E) . Nonlinear regression analysis was used to calculate an apparent Km of 150 ± 25 μM and a maximum reaction rate Vmax of 11 ± 0.7 nmol/mg/min. These values fall within the same range as those previously reported by two independent groups using a radiometric and an LC/MS-based assay (4, 8) . It should be emphasized that measured kinetic parameters for lipases are apparent values, which are dependent on the employed assay conditions, such as the limited solubility of the lipophilic substrates in aqueous media and the use of membrane preparations instead of purified enzyme. Moreover, Vmax values are highly dependent on transfection efficiency and isolation procedure.
Determination of kinetic parameters using a coupled enzyme approach is only valid if the reaction of interest is rate-limiting. To verify that SAG hydrolysis by DAGL-α was indeed the rate-limiting step under the optimized assay conditions, rather than downstream 2-AG hydrolysis by MAGL, we compared the reaction rates of 4 measurements on 4 independent plates (N = 4, n = 4, Z' ≥ 0.6). The average glycerol production from 2-AG hydrolysis by 1 μg MAGL-membranes (equal to the amount used in the DAGL-α assay) was 215 ± 24 pmol/min. In contrast, 2-AG production resulting from SAG hydrolysis by 10 μg DAGL-α-membranes was approximately 69 ± 7 pmol/min. These results clearly indicate that under the employed assay conditions, the initial reaction catalyzed by DAGL-α is rate-limiting.
To validate our optimized assay, we performed a number of control experiments (Fig. 3F) .
DAGL-α-overexpressing membranes incubated with vehicle (DMSO) served as a positive control, mockmembranes incubated with vehicle as a negative control. Incubation with broad-range serine hydrolase inhibitor THL reduced the observed signal to mock-levels. In a separate experiment, catalytically inactive mutant DAGL-α S472A also showed a signal equal to mock-levels (data not shown). In control experiments in which no substrate was added, the same background fluorescence was observed as in the mock-membranes, indicating that the observed background signal did not originate from spontaneous hydrolysis of exogenous SAG. To assess whether endogenous substrate in the mock-membranes To provide information about the useful dynamic range of our optimized assay, we performed an experiment with only positive and negative controls (n = 36) to generate a Z'-factor data plot (Fig. 3G) .
The solid lines represent the mean slope of the individual data points, and the dashed lines represent three standard deviations above and below the mean. The plot shows low intra-assay variability between individual data points and the Z'-factor for this experiment was 0.84. To assess the inter-assay variability of our assay, we determined the inter-assay coefficient of variation from eight independently measured 96-well plates (N = 8, n = 4). The inter-assay coefficient of variation was 9.4% for the positive controls and 9.6% for the negative controls.
To further validate our assay, we tested a selection of published DAGL-α inhibitors in doseresponse experiments to determine their inhibitory potency using the natural substrate-based fluorescence assay (Fig. 4A) . We found that of the three tested compounds, THL most potently inhibited DAGL-α activity (pIC50 = 8.4 ± 0.08), followed by KT109 (pIC50 = 7.6 ± 0.07). Of note, using a surrogate substrate assay with para-nitrophenol butyrate, we were unable to discriminate between THL and KT109 in terms of inhibitory potency, since low-nanomolar IC50-values reached the detection limit of the surrogate substrate assay. This observation emphasizes the value of using natural substrate assays for lead optimization purposes. Previously identified glycine sulfonamide inhibitor LEI-106 prevented SAG hydrolysis by DAGL-α with a pIC50 of 6.0 ± 0.07. An MAGL validation assay was performed to verify that the tested compounds inhibited DAGL-α activity and did not affect the downstream coupled enzyme reaction (pIC50 < 5, Fig. 4B ).
The reversible binding mode of LEI-106 enables us to report its inhibitory potency as an inhibition constant Ki via the Cheng-Prusoff equation (18) . In a prior study, we determined the potency of LEI-106 in a radiometric assay employing 1-oleoyl-2-[
14 C]arachidonoyl-sn-glycerol as the substrate, in which it inhibited DAGL-α activity with a Ki of 0.7 ± 0.08 μM (15), which is within the same range as determined using our fluorescence assay (Ki = 0.5 ± 0.09 μM). This demonstrates that our reported assay setup can be effectively used to evaluate DAGL-α inhibitors and that its results are consistent with those obtained using a different assay format. Evaluation of irreversible inhibitor kinetics using our real-time fluorescence assay will be a subject for future studies.
We next explored whether our assay could be used to measure DAGL activity in the mouse brain membrane proteome. As shown in Fig. 5 , the employed assay setup allows the use of mouse brain membrane preparations to quantify endogenous DAGL activity, with only minor modifications compared to the assay employing membrane preparations from DAGL-α-overexpressing HEK293T cells. We observed that endogenously expressed MAGL was sufficiently active to establish the coupled enzyme reaction, which eliminated the need to add additional MAGL-overexpressing membranes. Under these conditions, the initial step of SAG hydrolysis remained the rate-determining step, as reflected by the reaction rates of the vehicle-treated samples. The decrease in glycerol production upon incubation of the mouse brain membrane proteome with selective MAGL inhibitor JZL184 indicated that MAGL is responsible for 2-AG hydrolysis under the employed assay conditions, whereas contribution of ABHD6 and ABHD12 could not be detected. Incubation with irreversible DAGL inhibitors THL and KT109 resulted in a significant decrease in 2-AG production (Fig. 5A ). To validate that this effect was due to inhibition of DAGL activity, we performed a similar experiment with 2-AG as the substrate ( overexpressing membranes from transiently transfected HEK293T cells, but can also be employed to profile DAGL activity and inhibition in the mouse brain membrane proteome.
Conclusions
In summary, we have developed a real-time, natural substrate-based fluorescence assay for DAGL-α that serves as an alternative to the currently available radiometric or LC/MS-based methods. Employing a coupled enzyme approach, this assay can be used to determine DAGL-α activity in a continuous assay setup, circumventing the time-consuming isolation and fractionation of products and thus greatly improving throughput. Our method is not restricted to the use of DAGL-α-overexpressing membrane preparations, but can also be used to measure DAGL activity and inhibition in the mouse brain membrane proteome. The assay should thus be a valuable tool for rapid characterization of lead compounds and aid in the development of selective DAGL-α inhibitors that may serve as potential drug candidates for obesity and neurodegenerative diseases. and oxidized to dihydroxyacetone phosphate (DHAP) and H2O2 by glycerol-3-phosphate oxidase (GPO).
In the final step, the produced H2O2 is used by horseradish peroxidase (HRP) to oxidize commercially available Amplifu™Red to fluorescent resorufin, which is monitored in real-time using a plate reader (λex = 535 nm, λem = 595 nm). All measurements were performed in n = 4, and n = 8 for controls, with Z' ≥ 0.6. Data shown are means ± SEM. Statistical comparison was performed using unpaired Student's t-test; *** = P < 0.001, ** = P < 0.01, * = P < 0.05, ns = P > 0.05 versus vehicle-treated DAGL-α. by guest, on 
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